Human cytomegalovirus infection is a common viral infection, and many healthy people have no symptoms or only mild fever, tiredness, sore throat, and body aches. It often lasts a few days to a few weeks, but the virus then stays in the body for life in an inactive state. Human cytomegalovirus infection matters most in pregnancy, in newborn babies, and in people with weakened immune systems because it can cause hearing loss, vision problems, pneumonia, or other serious illness. Not everyone will have the same experience, and the risk of death is mainly in severe cases, especially in very premature infants or people with major immune suppression. Treatment often involves monitoring and supportive care, and some people with severe Human cytomegalovirus infection may need antiviral medicine.
How many people live with Human cytomegalovirus infection?
Worldwide, there is no single exact count for human cytomegalovirus (CMV), but widely used estimates suggest about 60% to 90% of adults have been infected, which is roughly 3 to 5 billion adults worldwide; the range varies by age, country, and the blood test used (Merck Manual Professional Edition, 2024). In the United States, the CDC says about 50% to 80% of adults have been infected by age 40, suggesting roughly 130 to 210 million U.S. adults are living with CMV infection (CDC, 2024).
Overview
Human cytomegalovirus infectionSymptoms
Human cytomegalovirus infection often causes no symptoms. When symptoms happen, they usually feel like a mild viral illness, with fever, tiredness, sore throat, swollen glands, and body aches; early symptoms of Human cytomegalovirus infection can resemble mono.
Outlook and prognosis
For most healthy children and adults, Human cytomegalovirus infection gets better on its own and does not cause lasting problems. Outlook is more serious in pregnancy, newborns, and people with weakened immune systems, where careful follow-up and treatment can make a real difference.
Causes and risk factors
Human cytomegalovirus infection spreads through body fluids. Risk rises during pregnancy, infancy, weakened immunity, close contact with young children, sex, blood transfusions, and organ transplants. Most infections reflect exposure, not lifestyle alone.
Genetic influences
Genetics usually play a limited role in Human cytomegalovirus infection itself. Still, genetic variations in immune system genes may affect how strongly someone responds, including the risk of more severe disease or problems before birth.
Diagnosis
Human cytomegalovirus infection is diagnosed with blood, saliva, urine, or tissue tests that look for the virus or your body's immune response. In babies before birth, ultrasound and amniotic fluid testing may help confirm the diagnosis of human cytomegalovirus infection.
Treatment and drugs
Human cytomegalovirus infection often needs only rest, fluids, and symptom relief, especially in otherwise healthy people. Severe illness, pregnancy-related concerns, or infection in newborns or people with weak immune systems may be treated with antiviral medicines and close monitoring.
Symptoms
Human cytomegalovirus infection often causes no symptoms at all, especially in otherwise healthy children and adults. When it does cause illness, it usually feels like a lingering viral infection with fever, fatigue, sore throat, and aches. Symptoms vary from person to person and can change over time. People with weakened immune systems, and babies infected before birth, can become much more ill.
Many people with Human cytomegalovirus infection feel completely well and only learn about it through testing. In others, the early symptoms of Human cytomegalovirus infection are mild and easy to mistake for a routine viral illness.
Fever, sore throat, swollen neck glands, and body aches are common when Human cytomegalovirus infection causes symptoms in otherwise healthy teens or adults. It can feel a lot like mono and may come with a general washed-out feeling.
Tiredness can linger for days or weeks and may feel stronger than you would expect from a simple cold. What once felt effortless can start to require more energy or focus.
Some people notice poor appetite, nausea, or discomfort under the right ribs if the liver is irritated. Less often, the skin or whites of the eyes can look yellow.
How people usually first notice Human cytomegalovirus infection?
Many people first notice human cytomegalovirus infection because they feel run-down in a way that seems bigger than an ordinary cold, with fatigue, fever, sore throat, swollen glands, or body aches. In healthy adults and children, the first signs of human cytomegalovirus infection are often mild or so vague that it can be mistaken for a short viral illness, and some people do not notice any symptoms at all. When CMV affects people with weakened immune systems or a baby during pregnancy, how human cytomegalovirus infection is first noticed can be very different and more serious, which is why new or unexplained symptoms should be checked by a clinician.
Types of Human cytomegalovirus infection
Human cytomegalovirus infection can show up in a few different ways depending on when the virus is picked up and how well the immune system is working. Symptoms don’t always look the same for everyone. Some people have no symptoms at all, while others develop a flu-like illness, and babies infected before birth can have a very different pattern. When people ask about the types of human cytomegalovirus infection, doctors usually mean these clinical forms.
Primary infection
This is the first time someone catches CMV, and many healthy people have no symptoms or only mild ones. Others may feel run-down, have fever, sore throat, swollen glands, or body aches that can last for days to weeks. It often resembles a lingering viral illness rather than something clearly specific.
CMV mononucleosis
Some people with a first CMV infection develop a mono-like illness with tiredness, fever, muscle aches, and swollen lymph nodes. Unlike classic mono, a very sore throat is often less prominent. For many, this can mean feeling unusually exhausted during normal routines like work, school, or exercise.
Reactivated CMV
After the first infection, CMV stays in the body and can become active again later, especially if the immune system is weakened. Symptoms may be mild or absent in otherwise healthy people, but those with reduced immunity can become much sicker. The balance of symptoms can shift over time depending on overall health and treatments that affect immunity.
Congenital CMV
This form happens when CMV is passed to a baby during pregnancy. Some newborns look well at first, while others have jaundice, a small head size, feeding problems, rash, or trouble hearing. Early symptoms of human cytomegalovirus infection in babies can be subtle, and some effects, especially hearing loss, may appear later.
Tissue-invasive CMV
In people with weakened immune systems, CMV can move beyond a general viral illness and affect specific organs. This may cause pneumonia with cough and shortness of breath, colitis with belly pain and diarrhea, hepatitis, eye infection with vision changes, or brain-related symptoms. These forms are usually more serious and need prompt medical care.
Can I slow down the onset of symptoms?
Usually no; there is no good evidence that lifestyle changes like diet, exercise, sleep, or supplements can meaningfully delay the start of symptoms from human cytomegalovirus infection once this virus becomes active. What can help is lowering the chance of infection or the virus becoming active again: careful handwashing and avoiding contact with saliva, urine, and other body fluids can reduce risk, and people at very high risk, such as some transplant recipients, may be offered antiviral medicine and regular monitoring to delay or prevent illness. These steps may lower risk or help catch problems early, but they cannot guarantee that symptoms will never happen.
What genetics can tell you about symptoms
For human cytomegalovirus infection, genetics usually cannot clearly predict which symptoms someone will have, how severe they will be, or exactly when they will start. In most cases, symptoms depend much more on factors like age, immune system strength, pregnancy timing, and whether the infection happens before birth, although rare inherited differences in immune system genes can make severe illness more likely in some people. For babies born with cytomegalovirus, genetic testing may sometimes help explain why one child is more affected than another, but it is not a routine way to forecast symptoms for most families.
Causes and risk factors
Human cytomegalovirus infection happens when CMV spreads through body fluids such as saliva, urine, blood, semen, vaginal fluids, or breast milk. It can also pass during pregnancy or birth, after an organ transplant, or through close contact with young children, especially in daycare settings. People with a weakened immune system, newborns, pregnant people, and transplant recipients have a higher risk of serious illness, and rare inherited immune system disorders can also increase vulnerability. Lifestyle and daily habits matter too, because sex without condoms and frequent contact with diapers or saliva can raise the chance of infection. Knowing the risks can help you feel more in control, and careful handwashing and asking about CMV infection during pregnancy may help lower risk.
What are the most common causes or risk factors?
Human cytomegalovirus infection is caused by catching a very common virus that spreads through close contact with body fluids such as saliva, urine, blood, semen, vaginal fluids, and breast milk. The biggest risk factors are frequent contact with young children, sex without condoms, pregnancy, and having a weakened immune system, such as after an organ transplant, with HIV, or during cancer treatment. There are no well-known inherited genetic risk factors for most people, and risk depends much more on exposure to the virus and how well the immune system can control it.
Environmental and biological risk factors
Human cytomegalovirus infection is common, and the chance of catching it depends mostly on exposure to infected body fluids and on how well the immune system can control the virus. Doctors often group risks into internal (biological) and external (environmental). These are some of the main risk factors for human cytomegalovirus infection across pregnancy, infancy, and adulthood.
Toddlers and preschoolers often shed CMV in saliva and urine for months, even when they seem completely well. Living with, caring for, or working closely with young children raises exposure risk.
CMV spreads through direct contact with saliva, urine, blood, semen, vaginal fluids, and breast milk. Repeated close contact with these fluids makes infection more likely.
People who have never had CMV do not have immune memory against it. After a first meaningful exposure, they are more likely to become infected than someone with past immunity.
Conditions or treatments that suppress the immune system, such as HIV, chemotherapy, or anti-rejection medicines, make it harder to control CMV. This raises the risk of a new infection and can also let an old infection become active again.
Genetic risk factors
Human cytomegalovirus infection is caused by a virus, not by an inherited disease gene. Still, the genes that help run the immune system can influence how well your body controls the virus after exposure. Most of these inherited effects are small or still being studied, and only a few are clear genetic risk factors for human cytomegalovirus infection. Carrying a genetic change doesn’t guarantee the condition will appear.
Inherited immune disorders: Rare inherited immune disorders can make CMV much harder to control. This is especially true when the gene change affects T cells, natural killer cells, or other virus-fighting defenses.
T-cell pathways: Some inherited changes weaken T-cell responses, which are important for keeping CMV quiet after the first infection. When that control is poor, severe or long-lasting illness becomes more likely.
NK-cell pathways: Natural killer cells act early against viruses, and certain inherited changes can blunt this first response. Differences in these pathways have been linked to more trouble clearing CMV in some families.
Virus-sensing genes: The body uses sensor genes to notice viruses and switch on antiviral signals. Some variants in these genes have been linked with a higher chance of symptomatic or more severe CMV, but the effect is usually modest.
HLA pattern: HLA genes are part of the body’s cell-recognition system and help immune cells spot infected cells. Certain HLA patterns may make CMV control stronger or weaker, although results can vary between populations.
Family history: A family history of unusual, severe, or repeated CMV infections can sometimes point to an inherited immune problem. People with the same risk factor can have very different experiences.
Lifestyle risk factors
Human cytomegalovirus infection often spreads through everyday contact with body fluids, so certain habits can raise or lower the chance of catching it or passing it on. The main lifestyle risk factors for human cytomegalovirus infection involve sexual behavior, hand hygiene, and close-contact caregiving routines. In people who are pregnant or immunocompromised, these habits matter even more because infection can have more serious consequences.
Cytomegalovirus can spread through semen and vaginal fluids, so sex without condoms or barriers can increase transmission risk. Having multiple sexual partners can further raise the chance of exposure.
Not washing hands well after contact with saliva, urine, or nasal secretions can make infection more likely. This is especially important after changing diapers, wiping a child’s nose, or handling toys that have been in a child’s mouth.
Sharing cups, utensils, toothbrushes, or food can pass infected saliva from one person to another. Frequent sharing with young children is a well-known route of exposure.
Close daily contact with toddlers and preschool children can increase exposure because they may shed the virus for long periods. Kissing young children on the mouth or cheek near saliva and not cleaning hands after caregiving tasks can increase risk further.
Risk prevention
Human cytomegalovirus infection often causes no symptoms, so prevention mainly comes down to reducing contact with body fluids that can carry the virus, especially saliva, urine, breast milk, semen, and vaginal fluids. This matters most during pregnancy and around babies and toddlers, since everyday moments like wiping a runny nose or sharing a spoon can spread cytomegalovirus without anyone realizing it. Prevention can mean both medical steps, like careful screening in some high-risk settings, and lifestyle steps, like handwashing.
Wash your hands well with soap and water after changing diapers, wiping noses or drool, feeding a young child, or handling toys. This is one of the most effective ways to lower the risk of human cytomegalovirus infection, especially for pregnant people and caregivers.
Do not share cups, utensils, food, toothbrushes, or pacifiers with young children. Saliva is a common route for spread, so small daily habits can make a real difference.
Using condoms and limiting exposure to semen and vaginal fluids can reduce sexual transmission of cytomegalovirus. This can be especially important if a partner may have a recent infection or if you are pregnant.
During pregnancy, be extra careful with hand hygiene and avoid kissing young children on the mouth or cheek if saliva is present. You can still show affection by kissing the head or giving hugs, which lowers contact with saliva.
Can you prevent Human cytomegalovirus infection?
You cannot fully prevent human cytomegalovirus infection, also called CMV, because the virus is very common and there is no vaccine yet. Still, you can lower the risk by washing your hands well after contact with saliva, mucus, or diapers, not sharing food, drinks, or toothbrushes with young children, and using safer sex practices. These steps matter most for people who are pregnant or have a weakened immune system, since CMV can be more serious for them.
Transmission
Human cytomegalovirus infection spreads through direct contact with body fluids such as saliva, urine, blood, semen, vaginal fluids, and breast milk, so it can pass during sex, through close contact with young children, through blood transfusion or organ transplant, and from a pregnant parent to the baby during pregnancy or birth. Many people looking up how human cytomegalovirus infection spreads are surprised that it usually does not move easily through casual everyday contact, like briefly being in the same room or touching an object.
Human cytomegalovirus infection is common, but it is not usually considered highly contagious in the way flu or COVID-19 are; the risk is higher with repeated close contact, especially with saliva or urine from young children. For many healthy adults it causes few or no symptoms, but avoiding contact with body fluids matters more during pregnancy and for people with weakened immune systems.
When to test your genes
For human cytomegalovirus infection, gene testing is usually not part of early detection; doctors rely on blood, urine, saliva, or tissue tests to look for the virus itself. Genetic testing may matter only in special situations, such as pregnancy, newborn evaluation, transplant care, or when antiviral resistance is suspected.
Diagnosis
Human cytomegalovirus infection is often diagnosed when symptoms, pregnancy screening, transplant follow-up, or abnormal lab results lead to testing. Many people have no symptoms at all, while others may have a mono-like illness, so the diagnosis of human cytomegalovirus infection usually depends on lab tests rather than symptoms alone. Doctors usually begin with a review of symptoms, medical history, pregnancy status, and any immune system problems to understand how likely the infection is and how urgent testing may be.
Blood tests can look for antibodies that suggest a recent or past cytomegalovirus infection. These results can help in some situations, but they may not be enough on their own to confirm a new active infection.
PCR tests look for cytomegalovirus genetic material in blood, saliva, urine, or other body fluids. This is one of the main tools used in how human cytomegalovirus infection is diagnosed, especially in newborns, pregnant people, and those with weakened immune systems.
If PCR finds the virus, doctors may measure how much is present in the blood. This can help show how active the infection is and can guide treatment decisions in transplant recipients or others at high risk.
In babies, diagnosis is most accurate when saliva or urine is tested within the first 3 weeks of life. Testing after that can show infection, but it may be harder to tell whether it was present before birth or picked up later.
How is Human cytomegalovirus infection diagnosed?
Doctors usually diagnose human cytomegalovirus, or CMV, with a blood, saliva, or urine test that looks for the virus itself or for signs that the body is reacting to it. If someone is very sick or has a weak immune system, doctors may also test other body fluids or a small tissue sample to see whether CMV is affecting an organ. In babies, saliva or urine is usually tested within the first 2 to 3 weeks after birth to tell a present-at-birth infection from one caught later.
Stages of Human cytomegalovirus infection
Human cytomegalovirus infection does not have defined progression stages. This is because it often causes no symptoms at all, may act like a short viral illness, or can stay quiet in the body and reactivate later rather than moving through a clear step-by-step pattern. Often the process begins when you notice changes in daily life, but doctors usually diagnose or monitor it with symptoms, a physical exam, and tests such as blood tests, urine or saliva testing, or scans when organ involvement is suspected. In newborns, pregnancy, or people with weakened immune systems, early symptoms of human cytomegalovirus infection may prompt closer follow-up because the effects can vary widely from mild to serious.
Outlook and prognosis
The outlook for human cytomegalovirus infection is usually very good in healthy children and adults, many of whom have mild symptoms or none at all and recover without lasting problems. Prognosis is more guarded in newborns infected before birth, because congenital infection can lead to permanent hearing loss, developmental delay, vision problems, or seizures, and some affected infants may worsen over time even if they seem well initially. People with weakened immune systems, such as transplant recipients or those with advanced HIV, can develop severe disease involving the lungs, liver, gut, brain, or eyes, but outcomes have improved substantially with antiviral treatment and careful monitoring. Mortality is generally low in otherwise healthy people, but it can be significant in severely immunocompromised patients and in critically ill infants with symptomatic congenital infection. Long-term follow-up is especially important for babies with congenital CMV because hearing and developmental complications may emerge months or years after birth.
Long-term effects
For many people, Human cytomegalovirus infection does not cause lasting problems, especially if the immune system is healthy. The long-term picture is often very different for newborns infected before birth and for people with weakened immune systems, who can develop ongoing complications affecting hearing, vision, the brain, or other organs. Thinking about the long-term effects helps explain why doctors pay close attention to pregnancy, newborn health, and immune status when they talk about prognosis.
Most healthy children and adults recover from Human cytomegalovirus infection without long-term health problems. The virus usually stays inactive in the body afterward and may never cause trouble again.
Human cytomegalovirus infection can become active again later, especially when the immune system is weakened by illness, transplant medicines, or HIV. In these situations, problems may return or appear for the first time months or years after the early symptoms of Human cytomegalovirus infection have passed.
Babies infected before birth can develop hearing loss that is present at birth or shows up later in childhood. The hearing changes may affect one or both ears and can range from mild to severe.
Congenital Human cytomegalovirus infection can affect brain development and lead to delays with movement, speech, learning, or behavior. Some children have mild challenges, while others may develop intellectual disability or seizures over time.
How is it to live with Human cytomegalovirus infection?
For many people, living with human cytomegalovirus infection means living with something they may barely notice at all, because the infection often causes no symptoms or only a short flu-like illness with fatigue, fever, and swollen glands. The picture can be very different for people with weakened immune systems, who may face a much heavier daily burden with vision problems, digestive symptoms, repeated medical visits, blood tests, and antiviral treatment. It can also affect the people around you, because CMV can spread through close contact with body fluids, so careful handwashing and extra caution around pregnant people, newborns, and anyone immunocompromised can become an important part of everyday life.
Treatment and drugs
Treatment for Human cytomegalovirus infection depends a lot on who is affected and how sick they are. In healthy children and adults, it often causes mild illness or no symptoms at all, so treatment is usually rest, fluids, and relief for fever or aches rather than antiviral drugs. For newborns, people with weakened immune systems, or those with serious organ involvement, doctors may use antiviral medicines to lower the amount of virus in the body and help prevent complications, although these drugs can have important side effects and need close monitoring. Not every treatment works the same way for every person, and in severe Human cytomegalovirus infection, care may also include follow-up hearing checks, eye exams, or support for affected organs.
Can you cure Human cytomegalovirus infection?
No, there is no cure that removes human cytomegalovirus infection, often called CMV, from the body completely. In many healthy people, the immune system brings the infection under control and symptoms get better on their own. When CMV causes serious illness, doctors can use antiviral medicines to lower the amount of virus and help prevent or treat complications, but these medicines do not fully clear the virus.
Non-drug treatment
When human cytomegalovirus infection causes symptoms, daily life can feel draining, with fever, fatigue, sore throat, or poor feeding in a baby. Non-drug care is mainly supportive, helping the body recover, reducing complications, and addressing any lasting effects on hearing, vision, movement, or development. Supportive therapies can be especially important for babies with congenital CMV and for people whose immune systems are weak.
Extra rest and good fluid intake can help many people with human cytomegalovirus infection get through fever, body aches, and fatigue. This kind of care does not treat the virus itself, but it can make recovery more manageable and help prevent dehydration.
Small, regular meals and enough calories can help when appetite is poor or swallowing feels uncomfortable. In babies who tire easily with feeds or are not gaining weight well, feeding support from a pediatric team can make day-to-day care safer and easier.
Babies born with human cytomegalovirus infection may develop hearing loss even if they seem well at first. Regular hearing tests help catch changes early so support such as hearing aids and speech services can begin sooner.
Some people living with human cytomegalovirus infection, especially those with weakened immunity, need eye exams to look for vision-threatening inflammation. Fast assessment is important if you notice blurred vision, floaters, or blind spots.
Your genes may have an impact on how drugs work for you
For people being treated for human cytomegalovirus infection, inherited differences in the body can sometimes affect how strongly an antiviral medicine works or how likely it is to cause side effects, such as low blood counts. In real life, this can mean one person does well on a usual dose, while another needs closer lab checks or a dose change because the medicine is harder on their body. Even so, gene-based drug testing, sometimes called pharmacogenomics, is not a routine part of CMV care for most people, and treatment decisions are still guided mainly by symptoms, blood tests, and overall health.
Pharmacological treatments
Treatment for Human cytomegalovirus infection depends a lot on who is affected and how severe the illness is. Many healthy adults do not need antiviral medicine, but treatment is often important for newborns with congenital infection and for people with weakened immune systems, such as after an organ transplant. The main medicines are ganciclovir and valganciclovir, with foscarnet, cidofovir, and sometimes maribavir used in more difficult cases. Not everyone responds to the same medication in the same way.
Ganciclovir is a standard antiviral for serious Human cytomegalovirus infection, especially in hospitalized people and some newborns with congenital CMV. It is usually given by vein and can help limit virus growth, but doctors watch closely for low blood counts and kidney problems.
Valganciclovir is a tablet or liquid form related to ganciclovir, so it is often used when someone is stable enough to be treated at home. It may be used for congenital CMV or after transplant, and it is one of the main medicines used when treating early symptoms of Human cytomegalovirus infection in higher-risk people.
Foscarnet may be used when CMV does not respond well to ganciclovir or valganciclovir, or when those drugs cause major side effects. It is given by vein and can be effective, but it often needs careful monitoring because it can strain the kidneys and upset mineral levels in the blood.
Cidofovir is another antiviral that may be considered for resistant Human cytomegalovirus infection when other options are not working. It is used less often because kidney side effects can be serious, so extra fluids and protective medicines are usually given with it.
Genetic influences
Most people who get human cytomegalovirus infection are infected because they were exposed to the virus, not because they inherited a single gene that causes it. Genetics is only one piece of the puzzle, but small inherited differences in the immune system can affect how well the body recognizes and controls CMV. This may help explain why human cytomegalovirus infection is mild in one person and more serious in another, especially in newborns or in people whose immune systems are weakened. Rarely, unusually severe or repeated human cytomegalovirus infection can be a clue to an inherited problem with the immune system, and doctors may then look more closely at genes involved in fighting infections. For many living with human cytomegalovirus infection, family history by itself does not predict what will happen, because exposure, age, pregnancy, and overall immune health matter a great deal too. Genetic testing is not routine for typical human cytomegalovirus infection, but it can sometimes be useful when the pattern suggests an underlying immune disorder.
Is Human cytomegalovirus infection genetic?
Genetics usually play a limited role in Human cytomegalovirus infection itself. Still, genetic variations in immune system genes may affect how strongly someone responds, including the risk of more severe disease or problems before birth.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are commonly found in the general population. Most do not have a direct effect on health and simply make up part of normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When people are treated for Human cytomegalovirus infection, the choice of medicine is usually shaped less by inherited genes and more by kidney function, blood counts, transplant status, pregnancy, and how serious the infection is. At this point, there is no widely used pharmacogenetic test that can reliably tell doctors which antiviral will work best or what dose is safest for most people with Human cytomegalovirus infection. Not every difference in response is genetic, but some people may still tolerate these drugs differently, which can affect side effects such as low blood counts or kidney problems. In everyday care, doctors usually depend on lab tests, medication review, and dose adjustments rather than a DNA test. Viral genetics often matter more here: changes in the cytomegalovirus itself can make medicines such as ganciclovir or valganciclovir work less well, so resistance testing may help guide a switch to another antiviral. If you are looking into how genetics affect treatment for Human cytomegalovirus infection, the clearest answer today is that testing the virus is often more useful than testing your own genes, although this could change as research moves forward.
Interactions with other conditions
For many people, Human cytomegalovirus infection causes few problems, but it can matter much more when another illness is already straining the body. In people living with HIV, cancer, or an organ transplant, CMV can wake up after being quiet and lead to serious problems such as pneumonia, hepatitis, eye disease, or inflammation in the digestive tract. Someone might notice their symptoms flare when another condition is active, especially if medicines that suppress the immune system are part of treatment. CMV can also complicate ulcerative colitis in some adults, where a flare that does not improve as expected may partly be linked to the virus. During pregnancy, a new CMV infection or reactivation is a separate concern because it can affect the developing baby, particularly hearing and brain development. Talk with your doctor about how your conditions may influence each other, since early symptoms of CMV infection can overlap with other illnesses and the right testing can help guide treatment.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Human cytomegalovirus infection?
Human cytomegalovirus infection can look a lot like mono, so the virus that causes mono is one of the main conditions doctors think about. The flu, COVID-19, and viral hepatitis can also cause similar symptoms, especially fever, extreme tiredness, body aches, or abnormal liver tests. In newborns, a few infections picked up during pregnancy, such as toxoplasmosis or rubella, can sometimes cause similar problems too.
History
Long before doctors could identify the virus itself, they were describing babies born with jaundice, enlarged organs, or hearing problems, and adults with severe illness after organ transplants or during major immune suppression. In the late 1800s and early 1900s, pathologists noticed unusually large cells with striking changes inside them under the microscope, which led to early names such as “cytomegalic inclusion disease.” At that stage, Human cytomegalovirus infection was recognized only through its effects, not through a clear understanding of the infection behind them.
By the 1950s, researchers were able to isolate the virus and show that it belonged to the herpesvirus family. This was an important turning point, because it helped explain why the infection could stay quiet in the body for years and then become active again later. Over time, doctors also learned that many infections cause few or no symptoms, while some can be much more serious in newborns and in people whose immune systems are weakened. That helped reshape older views that had focused mostly on the most severe cases.
In recent decades, awareness has grown around congenital infection, meaning infection passed to a baby during pregnancy. This matters in everyday life because some children seem well at birth and only later show signs such as hearing loss or delays in development, which changed how clinicians think about the early symptoms of Human cytomegalovirus infection. As testing improved, the condition became easier to recognize in hospitals, pregnancy care, and transplant medicine.
Treatment and prevention have also evolved. Antiviral medicines have improved care for some newborns and for people at high risk of serious disease, especially after transplantation. Today, the history of Human cytomegalovirus infection is less about a rare mystery seen under the microscope and more about a common infection that medicine has gradually learned to detect earlier, follow more closely, and manage more effectively.